FDA.reportPublic FDA data

cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection

RxCUI
1730194
RxNorm name
cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection
Display name
cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection
Full name
cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cisatracurium BesylateCISATRACURIUM BESYLATEHospira, Inc.67908e20-044d-454d-9c51-bf106e817bd02026-05-25Warnings, Adverse reactionsExact identifier
rxcui: 1730194
Cisatracurium BesylateCISATRACURIUM BESYLATECamber Pharmaceuticals Inc.d8b5eb77-b393-4cd7-86c5-d2a9d131f96d2026-04-30Warnings, Adverse reactionsExact identifier
rxcui: 1730194
Cisatracurium BesylateCISATRACURIUM BESYLATESomerset Therapeutics, LLCed91f65b-e002-43bd-bfa0-5ce8b89119e62026-04-29Warnings, Adverse reactionsExact identifier
rxcui: 1730194
Cisatracurium BesylateCISATRACURIUM BESYLATEEugia US LLC2cb05c7e-6228-4e2d-a270-7659e3db3fa72025-11-07Warnings, Adverse reactionsExact identifier
rxcui: 1730194
Cisatracurium BesylateCISATRACURIUM BESYLATEHikma Pharmaceuticals USA Inc.c5a63679-0c94-4e9d-9ac0-8ee3023bd9a62025-05-15Warnings, Adverse reactionsExact identifier
rxcui: 1730194
Cisatracurium besylateCISATRACURIUM BESYLATEGland Pharma Limited0bacc37a-5e7f-4f05-9206-56fc8041c1ad2025-04-04Warnings, Adverse reactionsExact identifier
rxcui: 1730194
CisatracuriumCISATRACURIUM BESYLATEFresenius Kabi USA, LLCf78a07e2-0d3b-4460-b29e-8c10c90afbda2025-02-21Warnings, Adverse reactionsExact identifier
rxcui: 1730194
Cisatracurium besylateCISATRACURIUM BESYLATECaplin Steriles Limited93101770-10a1-4bad-a762-289c793d8ace2025-01-17Warnings, Adverse reactionsExact identifier
rxcui: 1730194
cisatracurium besylateCISATRACURIUM BESYLATESandoz Inc291a55dd-ab45-4660-b513-4ecb729eb0512024-10-31Warnings, Adverse reactionsExact identifier
rxcui: 1730194
Cisatracurium besylateCISATRACURIUM BESYLATESlate Run Pharmaceuticals, LLC49185e78-d244-4426-90ef-ad109824eddb2024-08-29Warnings, Adverse reactionsExact identifier
rxcui: 1730194
cisatracurium besylateCISATRACURIUM BESYLATEZydus Pharmaceuticals USA Inc.f9e1a84b-d19e-46c5-b40f-944ac1543dac2024-08-16Warnings, Adverse reactionsExact identifier
rxcui: 1730194
Cisatracurium BesylateCISATRACURIUM BESYLATEMeitheal Pharmaceuticals Inc.1be30efe-4beb-411a-bf82-6e4ea68fd2622023-06-05Warnings, Adverse reactionsExact identifier
rxcui: 1730194
Cisatracurium BesylateCISATRACURIUM BESYLATEMeitheal Pharmaceuticals Inc.7c8c41b6-d07c-4740-84b7-603289104c592023-01-19Warnings, Adverse reactionsExact identifier
rxcui: 1730194
cisatracurium besylateCISATRACURIUM BESYLATEZydus Lifesciences Limitede145a40e-b046-4064-b35e-0da40ff3703e2022-11-05Exact identifier
rxcui: 1730194

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 14 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
67908e20-044d-454d-9c51-bf106e817bd0cisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]315These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 199520260525
291a55dd-ab45-4660-b513-4ecb729eb051cisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]312These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 199520241031
ed91f65b-e002-43bd-bfa0-5ce8b89119e6cisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]310These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 199520260429
f78a07e2-0d3b-4460-b29e-8c10c90afbdacisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]39These highlights do not include all the information needed to use Cisatracurium Besylate Injection safely and effectively. See full prescribing information for Cisatracurium Besylate Injection. Cisatracurium Besylate Injection, for intravenous use Initial U.S. Approval: 199520250221
2cb05c7e-6228-4e2d-a270-7659e3db3fa7cisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]36These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 199520251107
7c8c41b6-d07c-4740-84b7-603289104c59cisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]36These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 199520230119
f9e1a84b-d19e-46c5-b40f-944ac1543daccisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]35These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 199520240816
c5a63679-0c94-4e9d-9ac0-8ee3023bd9a6cisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]34These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION . CISATRACURIUM BESYLATE injection for intravenous use Initial U.S. Approval: 199520250515
0bacc37a-5e7f-4f05-9206-56fc8041c1adcisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]34These highlights do not include all the information needed to useCISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 199520250404
e145a40e-b046-4064-b35e-0da40ff3703ecisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]33CISATRACURIUM BESYLATE INJECTION20221105
d8b5eb77-b393-4cd7-86c5-d2a9d131f96dcisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]32These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection for intravenous use. Initial U.S. Approval: 199520260430
93101770-10a1-4bad-a762-289c793d8acecisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]32These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE Injection, for intravenous use Initial U.S. Approval: 199520250117
49185e78-d244-4426-90ef-ad109824eddbcisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]32These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 199520240829
1be30efe-4beb-411a-bf82-6e4ea68fd262cisatracurium besylate 10 MG in 5 ML Injection [PSN] · 5 ML cisatracurium 2 MG/ML Injection [SCD] · cisatracurium (as cisatracurium besylate) 10 MG per 5 ML Injection [SY]31These highlights do not include all the information needed to use CISATRACURIUM BESYLATE INJECTION safely and effectively. See full prescribing information for CISATRACURIUM BESYLATE INJECTION. CISATRACURIUM BESYLATE injection, for intravenous use Initial U.S. Approval: 199520230605